Human factor IX (LFB)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman factor IX (LFB)
Drug Alias Name人凝血因子9（LFB）Human factor IX biosimilar (GTC)Human factor IX biosimilar-GTCHuman factor IX biosimilarHuman factor IX biosimilar-ProGenetics +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factorBiologics > Biosimilar
Mechanisms of ActionCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsHemophilia B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryNetherlands
Original Approved Date2000/05/01
Country/TerritoryNetherlandsFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLfb Biotechnologies Sas
China Registration ClassN/A

Develop Information

Active CompaniesLfb Biotechnologies Sas
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeB02BD04
Related LinksWikipediaDrugBankKEGG